Uob.com.sg

United International Growth Fund
Funds Review
Fund Objective
Fund Details
The Fund aims to achieve long-term capital appreciation through investing mainly in shares in global LAUNCH DATE
emerging and developed markets, identified by the Managers as having good prospects for growth.
March 1995
FUND SIZE

S$174.25 million
NAV PRICE

(as at 30 Sep 08)
SUBSCRIPTION
Top 10 Holdings (As at 30 Sep 2008)
Asset Allocation (As at 30 Sep 2008)
Cash, CPF-OA & SRS
INITIAL INVESTMENT

By Country
SUB INVESTMENT
MANAGEMENT FEE
1.00% p.a.
SUBSCRIPTION FEE
5% (Cash,SRS)
3% (CPF-OA)
MINIMUM RSP
By Sector
S$100/month,
S$500/quarter
HSBC Institutional Trust
  Performance
7th April 95 To 30th September 08, Performance Based in -11.15% -15.59% -11.54% Fund Awards
-14.41% -18.69% -14.85% Fund Awards 03, 06 -26.60% -30.27% -29.57% SG S&P Inv. Funds Awards Source: Lipper • Performance as at
30 Sep 08, SGD basis, with dividends
and distributions reinvested, if any.
• Performance figures for 1 mth till 1
yr show the % change, while those
*The above chart reflects performance from the first exceeding 1 yr show the average annual
month end of the Fund. ^5% sales charge applied.
compounded return.
Contact Details
Benchmark (BM) : Apr 95 - Dec 96 : DBS 50 Index; Jan 97 - Dec 97 : MSCI AC Far East; Jan 98 - Hotline (24-hour):
Website: uobam.com.sg
IMPORTANT NOTICE AND DISCLAIMERS
A prospectus for the fund(s) (the "Fund(s)") may be obtained from the Manager or any of its appointed distributors. Investors should read the prospectus before deciding whether to subscribe for or purchase units in the Fund(s) ("Units"). All applications for Units must be made on application forms accompanying the prospectus or otherwise as described in the prospectus. Past performance of the Fund(s) or the Manager and any forecasts on the economy or markets are not indicative of
the future or likely performance of the Fund(s) or the Manager. Any extraordinary performance may be due to exceptional
circumstances which may not be sustainable. The value of Units and any income from the Fund(s) may fall as well as rise. The above information is strictly for information purposes only and must not be construed as an offer or solicitation to deal in Units, nor a recommendation to invest in any company mentioned herein. Investments in unit trusts are not obligations of, deposits in, or guaranteed or insured by UOB, UOBAM, or any affiliates or distributors. An investment in unit trusts is subject to investment risks and foreign exchange risks, including the possible loss of the principal amount invested. Investors may wish to seek advice from a financial adviser before making a commitment to invest in Units. In the event an investor chooses not to seek advice from a financial adviser, the investor should consider whether the Fund(s) in question is/are suitable for him.
UOB Asset Management Ltd Co. Reg. No.: 198600120Z

Source: http://www.uob.com.sg/assets/pdfs/personal/investments/p_internationalgrowth.pdf

Santana.ind

REGULAR PAPER A HISTOMORPHOMETRICAL STUDY OF THE EFFECTS OF ETHANOL ON ENAMEL FORMATION IN RAT MANDIBULAR MOLARS DURING PREGNANCY Luciana Barros Sant’Anna and Darcy de Oliveira ToselloDepartment of Morphology, Faculty of Odontology, State University of Campinas (UNICAMP), Piracicaba, SP, Brazil. ABSTRACT The consumption of alcohol during pregnancy causes fetal congenital malformat

Pharmacy news - december 2010

For Release December 2010 Blue Cross and Blue Shield of Alabama’s Pharmacy and Therapeutics (P & T) Committee recently approved updates to the Prescription Drug Guide and made clinical program changes to select medications. All information is accessible online at www.bcbsal.com .The P & T Committee consisting of doctors, pharmacists, nurses, and other healthcare pro

Copyright © 2010 Medicament Inoculation Pdf